Abstract
On-line haemodiafiltration differs from other forms of haemodialysis in that up to 20 L/h of dialysis fluid can be infused directly into the bloodstream during each treatment. That infused fluid must be free of chemical contaminants, sterile and pyrogen-free. Compliance with that requirement cannot be demonstrated by testing at the time of infusion. Instead, the infused fluid must be prepared using equipment that has been validated to produce sterile and pyrogen-free fluid when operated in accordance with the machine manufacturer’s instructions. It is the responsibility of the user of the machine to ensure those instructions are followed, including providing the dialysis machine with water and concentrates that meet the specifications set forth by the machine manufacturer. Properly designed systems for water treatment and distribution and concentrate preparation are central to achieving that goal. In addition, those systems must be subject to rigorous quality control that includes maintenance practices designed to prevent contamination of the dialysis and infusion fluids, coupled to monitoring that verifies the adequacy of the system design and maintenance program.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ledebo I. On-line preparation of solutions for dialysis: practical aspects versus safety and regulations. J Am Soc Nephrol. 2002;13:S78–83.
Ward RA. Water processing for hemodialysis. A historical perspective. Semin Dial. 1997;10:26–31.
World Health Organization. Guidelines for drinking water quality. 4th ed. WHO press, Geneva, Switzerland. 2011.
International Organization for Standardization. Water for haemodialysis and related therapies (ISO 13959:2014). Geneva: International Organization for Standardization; 2014.
International Organization for Standardization. Quality of dialysis fluid for haemodialysis and related therapies (ISO 11663:2014). Geneva: International Organization for Standardization; 2014.
Handelman GJ, Megdal PA, Handelman SK. Bacterial DNA in water and dialysate: detection and significance for patient outcomes. Blood Purif. 2009;27:81–5.
Henrie M, Ford C, Andersen M, et al. In vitro assessment of dialysis membrane as an endotoxin transfer barrier: geometry, morphology, and permeability. Artif Organs. 2008;32:701–10.
International Organization for Standardization. Guidance for the preparation and quality management of fluids for haemodialysis and related therapies (ISO 23500:2014). Geneva: International Organization for Standardization; 2014.
Williams KL. Endotoxins: pyrogens, LAL testing and depyrogenation. 2nd ed. New York: Marcel Dekker Inc; 2001.
New SE, Aikawa E. Cardiovascular calcification: an inflammatory disease. Circ J. 2011;75:1305–13.
McIntyre CW, Harrison LE, Eldehni MT, et al. Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6:133–41.
Yao Q, Axelsson J, Heimburger O, et al. Systemic inflammation in dialysis patients with end-stage renal disease: causes and consequences. Minerva Urol Nefrol. 2004;56:237–48.
Hasegawa T, Nakai S, Masakane I, et al. Dialysis fluid endotoxin level and mortality in maintenance hemodialysis: a nationwide cohort study. Am J Kidney Dis. 2015. doi:10.1053/j.ajkd.2014.12.009.
Susantitaphong P, Riella C, Jaber BL. Effect of ultrapure dialysate on markers of inflammation, oxidative stress, nutrition and anemia parameters: a meta-analysis. Nephrol Dial Transplant. 2013;28:438–46.
Kwan BC, Chow KM, Ma TK, et al. Effect of using ultrapure dialysate for hemodialysis on the level of circulating bacterial fragment in renal failure patients. Nephron Clin Pract. 2013;123:246–53.
Arizono K, Nomura K, Motoyama T, et al. Use of ultrapure dialysate in reduction of chronic inflammation during hemodialysis. Blood Purif. 2004;22:26–9.
Sitter T, Bergner A, Schiffl H. Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patients. Nephrol Dial Transplant. 2000;15:1207–11.
Ledebo I. On-line haemodiafiltration: technique and therapy. Adv Ren Replace Ther. 1999;6:195–208.
Polaschegg H-D, Roy T. Technical aspects of online hemodiafiltration. In: Ronco C, Canaud B, Aljama P, editors. Hemodiafiltration, Contrib Nephrol, vol. 158. Basel: Karger; 2007. p. 68–79.
Penne EL, Visser L, van den Dorpel MA. Microbiological quality and quality control of purified water and ultrapure dialysis fluids for online hemodiafiltration in routine clinical practice. Kidney Int. 2009;76:665–72.
Ebben JP, Hirsch DN, Luehmann DA, et al. Microbiologic contamination of liquid bicarbonate concentrate for hemodialysis. Trans Am Soc Artif Intern Organs. 1987;33:269–73.
Delin K, Attman PO, Dahlberg M. A clinical test of a new device for on-line preparation of dialysis fluid from bicarbonate powder: the Gambro BiCart. Dial Transplant. 1988;17:468–82.
Koda Y, Mineshima M. Advances and advantages in recent central dialysis fluid delivery system. Blood Purif. 2009;27 Suppl 1:23–7.
Schindler R, Beck W, Deppisch R, et al. Short bacterial DNA fragments: detection in dialysate and induction of cytokines. J Am Soc Nephrol. 2004;15:3207–14.
Glorieux G, Hulko M, Speidel R, et al. Looking beyond endotoxin: a comparative study of pyrogen retention by ultrafilters used for the preparation of sterile dialysis fluid. Sci Rep. 2014;4:6390.
Kawanishi H, Moriisha M, Sato T, et al. Fully automated dialysis system based on the central dialysis fluid delivery system. Blood Purif. 2009;27 Suppl 1:56–63.
Ward RA. Quality management of dialysis fluid for online convective therapies. In: Kawanishi H, Yamashita AC, editors. Hemodiafiltration – a new era, Contrib Nephrol, vol. 169. Basel: Karger; 2010. p. 1–11.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ward, R.A., Tattersall, J.E. (2016). Water Treatment and Safety Requirements. In: Nubé, M., Grooteman, M., Blankestijn, P. (eds) Hemodiafiltration. Springer, Cham. https://doi.org/10.1007/978-3-319-23332-1_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-23332-1_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-23331-4
Online ISBN: 978-3-319-23332-1
eBook Packages: MedicineMedicine (R0)